ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Ipsen SA

Ipsen SA (IPN)

113.00
0.70
(0.62%)
Closed April 28 11:30AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
113.00
Bid
112.60
Ask
113.20
Volume
55,575
111.40 Day's Range 113.10
99.70 52 Week Range 130.70
Market Cap
Previous Close
112.30
Open
112.60
Last Trade
15
@
113
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
76,880
Shares Outstanding
83,814,526
Dividend Yield
1.06%
PE Ratio
14.70
Earnings Per Share (EPS)
7.69
Revenue
3.37B
Net Profit
644.4M

About Ipsen SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Boulogne-billancourt, Hauts-de-seine, Fra
Founded
1970
Ipsen SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker IPN. The last closing price for Ipsen was 112.30 €. Over the last year, Ipsen shares have traded in a share price range of 99.70 € to 130.70 €.

Ipsen currently has 83,814,526 shares outstanding. The market capitalization of Ipsen is 9.47 € billion. Ipsen has a price to earnings ratio (PE ratio) of 14.70.

IPN Latest News

Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance

Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext:...

Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques rares

Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques rares Ipsen conclut un accord...

Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases

Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaborationFollowing development candidate validation, Ipsen will assume...

Ipsen publishes its 2023 Universal Registration Document

Ipsen publishes its 2023 Universal Registration Document    Ipsen publishes its 2023 Universal Registration Document PARIS, FRANCE, 17 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a...

Ipsen publie son Document d’enregistrement universel 2023

Ipsen publie son Document d’enregistrement universel 2023    Ipsen publie sonDocument d’enregistrement universel 2023 PARIS, FRANCE, 17 avril 2024 - Ipsen (Euronext : IPN ; ADR : IPSEY...

Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de voteet...

Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors

Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors Ipsen secures exclusive global rights for development and commercialization of...

Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de voteet...

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights and shares...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
16.96.50329877474106.1115.9105.385595111.64269675DE
43.33.00820419325109.7115.9104.664447109.30921058DE
1276.60377358491106115.999.776880106.31248967DE
26-4.3-3.66581415175117.311899.776393106.08866531DE
525.85.41044776119107.2130.799.772232110.59619331DE
15632.8841.038442336580.12130.7778729599.13226729DE
260-2.1-1.8245004344115.1130.734.211037088.73140328DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
carlson carlson 2 minutes ago
Thanks
CGAC
mick mick 3 minutes ago
2 YEARS; AEMD
www.stockscores.com/chart.asp?TickerSymbol=AEMD&TimeRange=950&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&avgType1=&movAvg1=&avgType2=&movAvg2=&candles=redgreen

2 YEARS;
[-chart]www.stockscores.com/chart.asp?Ticke
AEMD
weedtrader420 weedtrader420 3 minutes ago
Yeah, weedtrader420 investorshub bahahaha SUKU SUKU SUKU BITCOIN Kid Rock BAWITDABA $75,000 TARGET
BTCUSD
Myth Myth 3 minutes ago
Fleetwood Mac - Mr. Fantasy, feat. Dave Mason & Dave Amato (Live 1995, Tinley P, Chicago, IL, Aug 6)

https://www.youtube.com/watch?v=ZxVzEZvqaXo
mick mick 4 minutes ago
2 YEARS;
www.stockscores.com/chart.asp?TickerSymbol=FCEL&TimeRange=950&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&avgType1=&movAvg1=&avgType2=&movAvg2=&candles=redgreen


2 YEARS;
[-chart]www.stockscores.com/chart.asp?Ti
AEMD FCEL
BlazingStocks BlazingStocks 4 minutes ago
$AGBA

Bob Diamond sets sights on rivalling TikTok with social media start-up
https://www.ft.com/content/5baa7c56-e57b-4195-a8ff-bd7f95f48b2f
AGBA
mick mick 5 minutes ago
https://www.fuelcellenergy.com/

TEN YR;
www.stockscores.com/chart.asp?TickerSymbol=FCEL&TimeRange=10000&Interval=m&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=None&movAvg1=&avgType2=None&movAvg2=&Indicator1=RSI&I
FCEL
Rosym Rosym 5 minutes ago
NIO STOCK Short Squeeze🚀 Why NIO is Worth 2 Trillion Dollars💰💰

[yt]sZC5Jv4CsCE[/yt]
NIO
north40000 north40000 5 minutes ago
You are correct, and kiwi continues to be out to lunch in failing to acknowledge a line in one of DMC8’s links today that the Vascepa market is being retained because freedom from pancreatitis has not been shown by a generic clinical trial. The generics have the burden of proof.
AMRN
mrkirby mrkirby 6 minutes ago
Once they believed it, they started saying it was insider action.🐂🐂🐂🐂🐂🐂🐂🐂🐂🍒🍒🍒🍒🍒🍒🍒 LOL. Like dogs chasing their tails.
IFUS
SeaBlue SeaBlue 6 minutes ago
Good article about the DTC if you have time to read it.
https://www.encouragingangels.org/new-blog/2024/4/27/3tzuw68c4uq0id2lgkuci047ehyk4g
DTC
tat4tat tat4tat 6 minutes ago
You forgot to mention expenses.
CEOS
Kool Aid Man Kool Aid Man 6 minutes ago
He's apparently still involved in Spooze and made official filings on its behalf AFTER being forbidden by the SEC to have anything to do with ANY publicly traded company EVER. So why is he? CEO Paul Strickland should have made these filings with the SOS instead of a convicted criminal.
SPZI
Seminole Red Seminole Red 6 minutes ago
lol
dranesthesia1 dranesthesia1 7 minutes ago
We break .012 this week on our way to .03 minimum this leg
SPZI
MRc2 MRc2 7 minutes ago
$AGBA~
https://x.com/jctb1/status/1784647271440953590
AGBA
mick mick 7 minutes ago
need that current listing.$CYBL
CYBL
Nelson2 Nelson2 8 minutes ago
So we actually own crypto or just stake it? If we do own crypto what is the breakdown? Have gone thru financials but it isn’t clear?

“2023 Cash & Crypto Value: $26.7 million as of December 31, 2023, marking a 82% year-over-year increase.
Current Cash & Crypto Value: $36.5 mil
BTCS
DiscoverGold DiscoverGold 8 minutes ago
The most overbought stocks in the S&P 500
By: Barchart | April 28, 2024

• Alphabet $GOOGL, Chipotle Mexican Grill $CMG, and Charles Schwab $SCHW are among this week's most overbought stocks in the S&P 500.

pbs.twimg.com/media/GMN_-NiWsAAB6ye?format=png&name
CMG GOOGL SCHW
mick mick 8 minutes ago
thank you for your listings
Itsabdellio Itsabdellio 8 minutes ago
Good watch on SoFi earnings.

https://www.tiktok.com/t/ZTLHqeERX/
SOFI
SeaBlue SeaBlue 8 minutes ago
Enjoyed listening to Dowd, particularly his discussion of the Yen carry trade. Craig Hemke has talked about the Yen carry trade for years and how the arbitrage is exploited by traders. Hopefully Dowd is wrong about more banks having problems, but frankly i am surprised they have lasted this long (
FFMGF
trish 1846 trish 1846 9 minutes ago
Well I guess time will tell…

“CaptureCrete is a registered trademark of Carbon Limit Co under license to Smog Armor Co.”


About Smog Armor:
Smog Armor is at the forefront of eco-sustainability, dedicated to innovative solutions that positively impact the p
DRNK
eeprincipal eeprincipal 9 minutes ago
Actually you need a Market Cap of ~ $54mily to break even.
TPTW
mick mick 9 minutes ago
could do good good with greens stuff by biden

Your Recent History

Delayed Upgrade Clock